Evidence map›Paper›PMID 40262799›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2025

Impact of the COVID-19 pandemic on tuberculosis program performance in Alberta, Canada: a population-based evaluation.

Seun Akinfolarin, Divya Shah, Courtney Heffernan, Tamara Samardzic, Angela Lau, Robin Love, Amy Colquhoun, Ryan Cooper, Stacy Valaire, Alexander Doroshenko and 3 more

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Seun AkinfolarinDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Divya ShahDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Courtney HeffernanDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Tamara SamardzicDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Angela LauDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Robin LoveDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Amy ColquhounDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Ryan CooperDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Stacy ValaireDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Alexander DoroshenkoDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Mary Lou EgedahlDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Gregory TyrrellDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta.
Richard LongDepartment of Medicine, the Faculty of Medicine and Dentistry (Akinfolarin, Shah, Heffernan, Samardzic, Lau, Love, Cooper, Doroshenko, Egedahl, Long), University of Alberta; Alberta Health (Colquhoun), Government of Alberta; the School of Public Health (Colquhoun, Cooper, Doroshenko, Long), University of Alberta; Alberta Health Services (Valaire, Tyrrell), Government of Alberta; Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry (Tyrrell), University of Alberta, Edmonton, Alta. richard.long@ualberta.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic caused major disruptions to essential tuberculosis (TB) services globally. We evaluated the performance of the TB program in Alberta, Canada, in 2 periods - before and during the pandemic - to estimate the impact of those disruptions.

methodsWe applied 10 program performance indicators and their related targets and compared them by period. The performance indicators included a measure of decline in the age- and sex-adjusted incidence by population group, the proportion of recently arrived immigrants screened on time, and 5 case management and 3 close contact management indicators. We measured performance targets by time period and clinic type - outpatient versus virtual. We used interrupted time series analysis to estimate the impact of the COVID-19 pandemic response on timeliness of immigrant screening.

resultsSince 2009, the rate of disease has declined in the Canadian-born but not the foreign-born population. However, the rate of disease by population group was not different prepandemic versus during the pandemic. Program performance was not negatively affected by the pandemic in general, but there was a large reduction in immigration and, in turn, the number of immigrants referred for screening (37.6%) and contacts identified for assessment (71.8%) during the pandemic, associated with improvements to the proportion of referrals assessed (91.7% v. 96.6%, relative risk [RR] 0.949, 95% confidence interval [CI] 0.936-0.962); contacts assessed (81.7% v. 90.0%, RR 0.908, 95% CI 0.875-0.943), and contacts completing treatment of infection (90.4% v. 97.1%, RR 0.931, 95% CI 0.886-0.979). Among patients with TB disease, monitoring of treatment response was suboptimal, whereas other targets were met or nearly met. Virtual clinic performance tended to be worse during the pandemic than the outpatient clinics.

interpretationCOVID-19-related disruptions were not as substantial in the Alberta TB program as elsewhere, likely because of its centralized operational model and protection of its staff from secondment. However, no progress has been made toward reducing TB incidence. Better resourcing of prevention activity and a more responsive information system should be considered.

Indexed as

COVID-19Emigrants and ImmigrantsMass ScreeningTuberculosisAdultAlbertaCase ManagementFemaleHumansIncidenceMaleMiddle AgedPandemicsProgram EvaluationSARS-CoV-2

Identifiers

PMID40262799
PMCPMC12017818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.